Top

Open Access 06-05-2024 | Breast Cancer | Review

Effectiveness of dietetic care for cancer survivors in the primary care setting: A systematic review and meta-analysis of randomized controlled trials

Authors: Henriette G. Ryding, Lana J. Mitchell, Roshan R. Rigby, Lauren Ball, Julie Hobby, Lauren T. Williams

Published in: Journal of Cancer Survivorship

Abstract

Purpose

Nutrition plays an important role in cancer survivorship. This systematic review and meta-analysis aim to critically assess and quantify the effectiveness of nutrition care interventions provided by dietitians to survivors who have completed treatment for cancer.

Methods

A systematic review of randomized controlled trials (RCTs) published from January 2004 to November 2023 reporting the effectiveness of primary care dietetic interventions with adult cancer survivors was conducted. PubMed, Scopus, CINAHL, Embase, ProQuest and PsycINFO databases were searched for key terms. Meta-analyses were conducted where there were sufficient studies of the same cancer type and outcomes.

Results

Twelve RCTs representing 1138 cancer survivors (519 breast cancer; 75 prostate cancer; 544 colorectal cancer) were included. Primary outcome measures included weight loss (n = 6), quality of life (n = 2), reducing lymphedema-related arm volume (n = 2), nutritional status (n = 1) and increasing fruit and vegetable intake (n = 1). Weight loss was observed in studies where this was the primary outcome. Results for quality of life varied. Meta-analyses of RCTs with breast cancer survivors showed that dietitian intervention achieved a mean of 3.7 kg greater intentional weight loss and 2.3% greater body fat decrease than control (p < 0.0001).

Conclusions

This study provides evidence for the effectiveness of primary care dietetic interventions by dietitians with cancer survivors, particularly with respect to intentional weight and fat loss in breast cancer survivors.

Implications for cancer survivors

Dietitians can play a key role in managing weight and improving long term health outcomes and prognosis for cancer survivors beyond the acute care setting.

Available only for authorised users

Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.CrossRefPubMed

Rowland JH, et al. Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other? Cancer. 2013;119:2094–108. https://doi.org/10.1002/cncr.28060.CrossRefPubMed

Hewitt ME, et al. From cancer patient to cancer survivor : lost in transition. Washington, D.C.: National Academies Press; 2006. http://site.ebrary.com/id/10120674.

Jemal A, et al. The cancer atlas. 3rd ed. Atlanta GA: American Cancer Society; 2019. https://canceratlas.cancer.org/. Accessed 15 Apr 2023.

NCI. Statistics and Graphs. National Cancer Institute, Office of Cancer Survivorship. 2022. https://cancercontrol.cancer.gov/ocs/statistics. Accessed 10 Apr 2023.

Macmillan Cancer Support. Cancer Prevalence. 2023. https://www.macmillan.org.uk/about-us/what-we-do/research/cancer-prevalence#355989. Accessed 5 Nov 2023.

AIHW. Australia's health 2020 data insights. Australian Institute of Health and Welfare; 2020. https://www.aihw.gov.au/getmedia/be95235d-fd4d-4824-9ade-34b7491dd66f/aihw-aus-231.pdf.aspx?inline=true. Accessed 15 Aug 2023.

Okwuosa TM, et al. Cardiovascular disease in cancer survivors. Postgrad Med J. 2017;93(1096):82–90. https://doi.org/10.1136/postgradmedj-2016-134417.CrossRefPubMed

Jefford M, et al. Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study. Support. Care Cancer. 2017;25:3171–9. htpps://doi.org/https://doi.org/10.1007/s00520-017-3725-5.

10.

Berry NM, et al. Differences in chronic conditions and lifestyle behaviour between people with a history of cancer and matched controls. Med J Aust. 2014;201(2):96–100. https://doi.org/10.5694/mja13.10701.CrossRefPubMed

11.

Demark-Wahnefried W, et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2005;23(24):5814. https://doi.org/10.1200/JCO.2005.01.230.CrossRefPubMed

12.

Adams ML, et al. The impact of key modifiable risk factors on leading chronic conditions. Prev Med. 2019;120:113–8. https://doi.org/10.1016/j.ypmed.2019.01.006.CrossRefPubMed

13.

Rock CL, et al. American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin. 2022;72(3):230–62. https://doi.org/10.3322/caac.21719.CrossRefPubMed

14.

Andreyev H, et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998;34(4):503–9. https://doi.org/10.1016/S0959-8049(97)10090-9.CrossRefPubMed

15.

Davies N, et al. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer. 2011;105(1):S52–73. https://doi.org/10.1038/bjc.2011.423.CrossRefPubMedPubMedCentral

16.

Ravasco P. Nutrition in cancer patients. J Clin Med. 2019;8(8):1211.CrossRefPubMedPubMedCentral

17.

WWCF. World Wide Cancer Fund/Cancer Prevention Recommendations. Diet, Activity and Cancer. 2023. https://www.wcrf.org/diet-activity-and-cancer/cancer-prevention-recommendations/. Accesssed 20 May 2023.

18.

Clinton SK, et al. The world cancer research fund/American institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr. 2020;150(4):663–71. https://doi.org/10.1093/jn/nxz268.CrossRefPubMed

19.

ICDA. International Compentency Standards for Dietitian-Nutritionists. 2016. https://internationaldietetics.org/wp-content/uploads/2023/05/International-Competency-Standards-for-Dietitian-Nutritionists.pdf. Accessed 1 Feb 2024.

20.

Mitchell LJ, et al. Effectiveness of Dietetic Consultations in Primary Health Care: A Systematic Review of Randomized Controlled Trials. J Acad Nutr Diet. 2017;117(12):1941–62. https://doi.org/10.1016/j.jand.2017.06.364.CrossRefPubMed

21.

Ravasco P, et al. Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr. 2012;96(6):1346–53. https://doi.org/10.3945/ajcn.111.018838.CrossRefPubMed

22.

Loprinzi CL, et al. Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapy. Oncology. 1996;53(3):228–32. https://doi.org/10.1159/000227565.CrossRefPubMed

23.

Taberna M, et al. The multidisciplinary team (MDT) approach and quality of care. Front Oncol. 2020;10:85. https://doi.org/10.3389/fonc.2020.00085.CrossRefPubMedPubMedCentral

24.

Leach CR, et al. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv. 2015;9:239–51. https://doi.org/10.1007/s11764-014-0403-1.CrossRefPubMed

25.

Wang S, et al. Benefits of dietary management in breast cancer patients: a systematic review and meta-analysis. Nutr Cancer. 2022;74(5):1580–92. https://doi.org/10.1080/01635581.2021.1957129.CrossRefPubMed

26.

Lake B, et al. Effectiveness of weight loss interventions in breast cancer survivors: a systematic review of reviews. BMJ Open. 2022;12(10): e062288. https://doi.org/10.1136/bmjopen-2022-062288.CrossRefPubMedPubMedCentral

27.

Reeves MM, et al. Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev. 2014;15(9):749–68. https://doi.org/10.1111/obr.12190.CrossRefPubMed

28.

Mohamad H, et al. The effect of dietary and exercise interventions on body weight in prostate cancer patients: a systematic review. Nutr Cancer. 2015;67(1):43–60. https://doi.org/10.1080/01635581.2015.976313.CrossRefPubMed

29.

Peričić TP, Tanveer S. Why systematic reviews matter: A brief history, overview and practical guide for authors. Cochrane International Mobility Programme. 2019. https://www.elsevier.com/en-au/connect/why-systematic-reviews-matter. Accessed Jul 2023.

30.

Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9. https://doi.org/10.1016/j.ijsu.2010.02.007.CrossRefPubMed

31.

National Center for Chronic Disease Prevention and Health Promotion (U.S.); Centers for Disease Control Prevention (U.S.); Lance Armstrong Foundation. A national action plan for cancer survivorship: advancing public health strategies. 2004. https://stacks.cdc.gov/view/cdc/6536. Accessed 10 Jul 2023.

32.

President's Cancer Panel. Living beyond cancer: finding a new balance, 2003–2004 annual report. Bethesda: National Cancer Institute; 2004. https://deainfo.nci.nih.gov/advisory/pcp/annualReports/index.htm. Accessed 10 Jul 2023.

33.

Covidence Systematic Review Software. Covidence systematic review software. 2023. https://www.covidence.org/. .Accessed 15 Feb 2023.

34.

Higgins JP, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343. https://doi.org/10.1136/bmj.d5928.

35.

Ryan R. Cocharane Consumers and Communication Review Group. Cochrane Consumers and Communication Group: meta-analysis. 2016. http://cccrg.cochrane.org. Accessed 10 Dec 2023.

36.

The Jamovi Project. Jamovi, (Version 2.3) [Computer Software]. 2022. https://www.jamovi.org. . Accessed 15 Nov 2023.

37.

Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Statistic Software. 2010;36:1–48. https://doi.org/10.18637/jss.v036.i03.CrossRef

38.

Pathak M, et al. Which is the preferred measure of heterogeneity in meta-analysis and why? A revisit. Biostat Biometrics Open Acc. 2017;1:1–7.

39.

IntHout J, et al. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6:7. https://doi.org/10.1136/bmjopen-2015-010247.CrossRef

40.

Viechtbauer W, Cheung MWL. Outlier and influence diagnostics for meta-analysis. Res synth Methods. 2010;1(2):112–25. https://doi.org/10.1002/jrsm.11.CrossRefPubMed

41.

Napierala MA. What is the Bonferroni correction? Aaos Now. 2012;40–41. https://link.gale.com/apps/doc/A288979427/HRCA?u=anon~d1065264&sid=googleScholar&xid=c03f33d9.

42.

Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994:1088–101. https://doi.org/10.2307/2533446.

43.

Higgins JP. Cochrane handbook for systematic reviews of interventions version 5.0. 1. The Cochrane Collaboration. 2008. https://training.cochrane.org/handbook. Accessed 5 Aug 2023.

44.

Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. https://doi.org/10.1016/j.ijsu.2021.105906.CrossRefPubMed

45.

Alavi DT, et al. Effect of a one-year personalized intensive dietary intervention on body composition in colorectal cancer patients: Results from a randomized controlled trial. Clinical Nutrition ESPEN. 2023;57:414–22. https://doi.org/10.1016/j.clnesp.2023.06.037.CrossRefPubMed

46.

Cho SW, et al. Effect of 8-week nutrition counseling to increase phytochemical rich fruit and vegetable consumption in korean breast cancer patients: a randomized controlled trial. Clin Nutri Res. 2014;3(1):39–47. https://doi.org/10.7762/cnr.2014.3.1.39.CrossRef

47.

Yoo HJ, et al. Korean translation and validation of the functional assessment of cancer therapy-breast (FACT-B) scale version 4. Qual Life Res. 2005;14:1627–32. https://doi.org/10.1007/s11136-004-7712-1.CrossRefPubMed

48.

Harrigan M, et al. Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) study. J Clin Oncol. 2016;34(7):669. https://doi.org/10.1200/JCO.2015.61.6375.CrossRefPubMed

49.

Jen KLC, et al. Improvement of metabolism among obese breast cancer survivors in differing weight loss regimens. Obes Res. 2004;12(2):306–12. https://doi.org/10.1038/oby.2004.38.CrossRefPubMed

50.

Djuric Z, et al. Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. Obes Res. 2002;10(7):657–65. https://doi.org/10.1038/oby.2002.89.CrossRefPubMed

51.

Reeves M, et al. The Living Well after Breast Cancer™ Pilot Trial: A weight loss intervention for women following treatment for breast cancer. Asia Pac J Clin Oncol. 2017;13(3):125–36. https://doi.org/10.1111/ajco.12629.CrossRefPubMed

52.

Ware JE Jr, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol. 1998;51(11):903–12. https://doi.org/10.1016/S0895-4356(98)00081-X.CrossRefPubMed

53.

Yellen SB, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13(2):63–74. https://doi.org/10.1016/S0885-3924(96)00274-6.CrossRefPubMed

54.

Hormes JM, et al. The body image and relationships scale: development and validation of a measure of body image in female breast cancer survivors. J Clin Oncol. 2008;26(8):1269–74. https://doi.org/10.1200/JCO.2007.14.2661.CrossRefPubMed

55.

Reeves MM, et al. Effect of a remotely delivered weight loss intervention in early-stage breast cancer: randomized controlled trial. Nutrients. 2021;13(11):4091. https://doi.org/10.3390/nu13114091.CrossRefPubMedPubMedCentral

56.

Reeves MM, et al. Living well after breast cancer randomized controlled trial protocol: evaluating a telephone-delivered weight loss intervention versus usual care in women following treatment for breast cancer. BMC Cancer. 2016;16(1):1–17. https://doi.org/10.1186/s12885-016-2858-0.CrossRef

57.

Greene JG. Constructing a standard climacteric scale. Maturitas. 2008;61(1–2):78–84. https://doi.org/10.1016/j.maturitas.2008.09.011.CrossRefPubMed

58.

Maybon L, et al. Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors. Oncology Nursing Society. Oncol Nurs Forum. 2013;40(6):549. https://doi.org/10.1188/13.ONF.549-557.

59.

Hays RD, et al. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18:873–80. https://doi.org/10.1007/s11136-009-9496-9.CrossRefPubMedPubMedCentral

60.

Thewes B, et al. The concerns about recurrence questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors. J Cancer Surviv. 2015;9:68–79. https://doi.org/10.1007/s11764-014-0383-1.CrossRefPubMed

61.

Shaw C, et al. Randomized controlled trial comparing a low‐fat diet with a weight‐reduction diet in breast cancer‐related lymphedema. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2007;109:10:1949–56. https://doi.org/10.1002/cncr.22638.

62.

Shaw C, et al. A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer. 2007;110(8):1868–74. https://doi.org/10.1002/cncr.22994.CrossRefPubMed

63.

Baguley BJ, et al. Mediterranean-style dietary pattern improves cancer-related fatigue and quality of life in men with prostate cancer treated with androgen deprivation therapy: A pilot randomised control trial. Clin Nutr. 2021;40(1):245–54. https://doi.org/10.1016/j.clnu.2020.05.016.CrossRefPubMed

64.

Baguley BJ, et al. The effect of nutrition therapy and exercise on cancer-related fatigue and quality of life in men with prostate cancer: a systematic review. Nutrients. 2017;9(9):1003. https://doi.org/10.3390/nu9091003.CrossRefPubMedPubMedCentral

65.

Mohamad H, et al. A self-help diet and physical activity intervention with dietetic support for weight management in men treated for prostate cancer: pilot study of the Prostate Cancer Weight Management (PRO-MAN) randomised controlled trial. Br J Nutr. 2019;122(5):592–600. https://doi.org/10.1017/S0007114519001090.CrossRefPubMed

66.

Aaronson NK, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI J National Cancer Institute. 1993;85(5):365–76.CrossRef

67.

Chu D, et al. Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients. J Comp Eff Res. 2014;3(5):523–31. https://doi.org/10.2217/cer.14.41.CrossRefPubMed

68.

Henriksen HB, et al. The Norwegian dietary guidelines and colorectal cancer survival (CRC-NORDIET) study: a food-based multicentre randomized controlled trial. BMC Cancer. 2017;17(1):1–17. https://doi.org/10.1186/s12885-017-3072-4.CrossRef

69.

Ho M, et al. Effects of dietary and physical activity interventions on generic and cancer-specific health-related quality of life, anxiety, and depression in colorectal cancer survivors: a randomized controlled trial. J Cancer Surviv. 2020;14:424–33. https://doi.org/10.1007/s11764-020-00864-0.CrossRefPubMedPubMedCentral

70.

Ho JW, et al. Study protocol for “Moving Bright, Eating Smart”–A phase 2 clinical trial on the acceptability and feasibility of a diet and physical activity intervention to prevent recurrence in colorectal cancer survivors. BMC Public Health. 2013;13(1):1–10. https://doi.org/10.1186/1471-2458-13-487.CrossRef

71.

Shu X, et al. Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women’s Health Study. Eur J Clin Nutr. 2004;58(1):17–23. https://doi.org/10.1038/sj.ejcn.1601738.CrossRefPubMed

72.

Lam CL, et al. Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health. 2008;11(2):295–303. https://doi.org/10.1111/j.1524-4733.2007.00233.x.CrossRefPubMed

73.

Ware JE, et al. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMed

74.

Lam CL, et al. Is the standard SF-12 health survey valid and equivalent for a Chinese population? Qual Life Res. 2005;14:539–47. https://doi.org/10.1007/s11136-004-0704-3.CrossRefPubMed

75.

Ward WL, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res. 1999;8:181–95. https://doi.org/10.1023/A:1008821826499.CrossRefPubMed

76.

Yu CL, et al. Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the functional assessment of cancer therapy–general (FACT-G) scale. Cancer. 2000;88(7):1715–27. https://doi.org/10.1002/(SICI)1097-0142(20000401)88:7%3c1715::AID-CNCR28%3e3.0.CO;2-K.CrossRefPubMed

77.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed

78.

Wang X, et al. Personalized nutrition intervention improves nutritional status and quality of life of colorectal cancer survivors in the community: A randomized controlled trial. Nutrition. 2022;103:111835. https://doi.org/10.1016/j.nut.2022.111835.CrossRefPubMed

79.

Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211. https://doi.org/10.1016/0749-5978(91)90020-T.CrossRef

80.

Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. https://doi.org/10.1056/NEJMoa012512.CrossRefPubMedCentral

81.

DGA. Dietary Guidelines for Americans. 2023. https://www.dietaryguidelines.gov/. Accessed 10 Nov 2023.

82.

Bandura A. Social cognitive theory: an agentic perspective. Annu Rev Psychol. 2001;51(1):1–26. https://doi.org/10.1146/annurev.psych.52.1.1.

83.

Franz MJ, et al. Exchange lists: revised 1986. J Am Diet Assoc. 1987;87(1):28–34.CrossRefPubMed

84.

WCRF/AICR. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007. https://www3.paho.org/hq/dmdocuments/2011/nutrition-AICR-WCR-food-physical-activ.pdf. Accessed 15 Jul 2023.

85.

Jensen MD, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J. Am. Coll. Cardiol. 2014. https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=7c28596b33491c05d557becba3861acc0562df51. Accessed 15 Dec 2023.

86.

WCRF/AMIR. Physical Activity and Cancer: A Global Perspective. Continuous Update Project Expert Report 2018. World Cancer Research Fund. American Institute for Cancer Research. 2018. https://www.wcrf.org/wp-content/uploads/2021/02/Summary-of-Third-Expert-Report-2018.pdf. Accessed 10 Jul 2023.

87.

Harris SR, et al. Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ. 2001;164(2):191–9.PubMedPubMedCentral

88.

Rollnick S, Miller WR. What is motivational interviewing? Behav Cogn Psychother. 1995;23(4):325–3334. https://doi.org/10.1017/S135246580001643X.

89.

Dietitians Association of Australia. DAA best practice guidelines for the treatment of overweight and obesity in adults 2012. https://www.pennutrition.com/resources/PEN_resources/DAA%20PDFs/FINAL-DAA-obesity-guidelines-report-25th-January-2011-2.pdf. Accessed 30 Aug 2023.

90.

Ernæring NRf. Kostråd for å fremme folkehelsen og forebygge kroniske sykdommer: metodologi og vitenskapelig kunnskapsgrunnlag. Helsedirektoratet Oslo; 2011.

91.

Schwarzer R, Luszczynska A. How to overcome health-compromising behaviors: The health action process approach. Eur Psychol. 2008;13(2):141–51. https://doi.org/10.1027/1016-9040.13.2.141.CrossRef

92.

Aprile G, et al. The clinical value of nutritional care before and during active cancer treatment. Nutrients. 2021;13(4):1196. https://doi.org/10.3390/nu13041196.CrossRefPubMedPubMedCentral

93.

Langius JA, et al. Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo) radiotherapy: a systematic review. Clin Nutr. 2013;32(5):671–8. https://doi.org/10.1016/j.clnu.2013.06.012.CrossRefPubMed

94.

Denlinger CS, et al. Survivorship: Nutrition and weight management, version 2.2014. J Natl Compr Canc Netw. 2014;12(10):1396–406.CrossRefPubMedPubMedCentral

95.

Chlebowski RT, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst. 2006;98(24):1767–76. https://doi.org/10.1093/jnci/djj494.CrossRefPubMed

96.

Williams LT, et al. How effective are dietitians in weight management? A systematic review and meta-analysis of randomized controlled trials. Healthcare. 2019;7(1):20. https://doi.org/10.3390/healthcare7010020.CrossRefPubMedPubMedCentral

97.

Sun Y, et al. The effectiveness and cost of lifestyle interventions including nutrition education for diabetes prevention: a systematic review and meta-analysis. J Acad Nutr Diet. 2017;117(3):404–21. https://doi.org/10.1016/j.jand.2016.11.016. (e36).CrossRefPubMedPubMedCentral

98.

Hawkins NA, et al. Health-related behavior change after cancer: results of the American Cancer Society’s studies of cancer survivors (SCS). J Cancer Surviv. 2010;4:20–32. https://doi.org/10.1007/s11764-009-0104-3.CrossRefPubMed

99.

Imayama I, et al. Weight, inflammation, cancer-related symptoms and health-related quality of life among breast cancer survivors. Breast Cancer Res Treat. 2013;140:159–76. https://doi.org/10.1007/s10549-013-2594-y.CrossRefPubMedPubMedCentral

100.

LeVasseur N, et al. Optimising weight-loss interventions in cancer patients—A systematic review and network meta-analysis. PLoS ONE. 2021;16(2): e0245794. https://doi.org/10.1371/journal.pone.0245794.CrossRefPubMedPubMedCentral

101.

Cruz-Jentoft AJ, Sayer AA. Sarcopenia. The Lancet. 2019;393(10191):2636–46. https://doi.org/10.1016/S0140-6736(19)31138-9.CrossRef

102.

Prado CM, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35. https://doi.org/10.1016/S1470-2045(08)70153-0.CrossRefPubMed

103.

Davis MP, Panikkar R. Sarcopenia associated with chemotherapy and targeted agents for cancer therapy. Ann Palliat Med. 2019;8(1):86–101. https://doi.org/10.21037/apm.2018.08.02.CrossRefPubMed

104.

Prado CM, et al. Nutrition interventions to treat low muscle mass in cancer. J Cachexia Sarcopenia Muscle. 2020;11(2):366–80. https://doi.org/10.1002/jcsm.12525.CrossRefPubMedPubMedCentral

105.

Johnston EA, et al. Association of protein intake with recurrence and survival following primary treatment of ovarian cancer. Am J Clin Nutr. 2023. https://doi.org/10.1016/j.ajcnut.2023.05.002.CrossRefPubMed

106.

Dietitians Australia. Health behaviour and weight management role statement. 2022. https://dietitiansaustralia.org.au/working-dietetics/standards-and-scope/role-statements/health-behaviour-and-weight-management-role-statement. Accessed 10 Dec 2023.

107.

Rigby RR, et al. The use of behavior change theories in dietetics practice in primary health care: a systematic review of randomized controlled trials. J Acad Nutr Diet. 2020;120(7):1172–97. https://doi.org/10.1016/j.jand.2020.03.019.CrossRefPubMed

108.

Perperidi M, et al. Identifying the effective behaviour change techniques in nutrition and physical activity interventions for the treatment of overweight/obesity in post-treatment breast cancer survivors: a systematic review. Cancer Causes Control. 2023:1–21. https://doi.org/10.1007/s10552-023-01707-w.

109.

Ball L, et al. Quality of development and reporting of dietetic intervention studies in primary care: a systematic review of randomised controlled trials. J Hum Nutr Diet. 2018;31(1):47–57. https://doi.org/10.1111/jhn.12526.CrossRefPubMed

110.

Kelly J, et al. Digital disruption of dietetics: are we ready? J Hum Nutr Diet. 2021;34(1):134–46. https://doi.org/10.1111/jhn.12827.CrossRefPubMed

111.

Farhana A, Rehman A. Metabolic consequences of weight reduction. Treasure Island (FL): StatPearls Publishing; 2021.

112.

Buono G, et al. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study. Breast Cancer Res Treat. 2020;182:401–9. https://doi.org/10.1007/s10549-020-05701-7.CrossRefPubMedPubMedCentral

113.

Ross LJ, et al. Effectiveness of dietetic consultation for lowering blood lipid levels in the management of cardiovascular disease risk: a systematic review and meta-analysis of randomised controlled trials. Nutr Diet. 2019;76(2):199–210. https://doi.org/10.1111/1747-0080.12509.CrossRefPubMedPubMedCentral

114.

Phillips JL, Currow DC. Cancer as a chronic disease. Collegian. 2010;17(2):47–50. https://doi.org/10.1016/j.colegn.2010.04.007.CrossRefPubMed

115.

Campos M, et al. Cancer-related fatigue: a practical review. Ann Oncol. 2011;22(6):1273–9. https://doi.org/10.1093/annonc/mdq458.CrossRefPubMed

116.

Van der Steeg A, et al. The value of quality of life and health status measurements in the evaluation of the well-being of breast cancer survivors. Eur J Surg Oncol (EJSO). 2008;34(11):1225–30. https://doi.org/10.1016/j.ejso.2007.10.009.CrossRefPubMed

117.

Pequeno NPF, et al. Quality of life assessment instruments for adults: a systematic review of population-based studies. Health Qual Life Outcomes. 2020;18(1):1–13. https://doi.org/10.1186/s12955-020-01347-7.CrossRef

118.

Luckett T, et al. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol. 2011;22(10):2179–90. https://doi.org/10.1093/annonc/mdq721.CrossRefPubMed

119.

Howatson A, et al. The contribution of dietitians to the primary health care workforce. J Prim Health Care. 2015;7(4):324–32. https://doi.org/10.1071/HC15324.CrossRefPubMed

Title: Effectiveness of dietetic care for cancer survivors in the primary care setting: A systematic review and meta-analysis of randomized controlled trials
Authors: Henriette G. Ryding
Lana J. Mitchell
Roshan R. Rigby
Lauren Ball
Julie Hobby
Lauren T. Williams
Publication date: 06-05-2024
Publisher: Springer US
Keywords: Breast Cancer
Breast Cancer
Published in: Journal of Cancer Survivorship
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-024-01583-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine